Resultados semestrales 2025, 30 de julio de 2025 Taylor Wimpey (lon:tw)
sábado, 10 de mayo de 2025
Suscribirse a:
Enviar comentarios (Atom)
Noticias empresas
-
-
How The Narrative On Shell (LSE:SHEL) Is Shifting With New Targets And LNG Developments - Shell’s analyst fair value estimate has been updated to £34.65 from £32.62, a change of about 6.2% that puts fresh focus on where the stock might sit in up...Hace 3 horas
-
Trump slaps steep tariffs on patented drug imports - The 100% tariff will go into effect on July 31 for several major pharmaceutical companies — with full-scale implementation to begin in September.Hace 11 horas
-
3 Consistent Dividend Payers Outperforming in 2026: VZ, PEP, MO - Companies with a long history of consistent dividend payouts often offer a nice shield against volatility while generating an income stream, with these thr...Hace 11 horas
-
3 Consistent Dividend Payers Outperforming in 2026: VZ, PEP, MO - Companies with a long history of consistent dividend payouts often offer a nice shield against volatility while generating an income stream, with these thr...Hace 11 horas
-
3 Consistent Dividend Payers Outperforming in 2026: VZ, PEP, MO - Companies with a long history of consistent dividend payouts often offer a nice shield against volatility while generating an income stream, with these thr...Hace 11 horas
-
Diageo (DEO) Cuts Outlook on Weak U.S. Alcohol Demand - Diageo plc (NYSE:DEO) ranks among the oversold European stocks to buy. On March 3, TD Cowen maintained its Hold rating on Diageo plc (NYSE:DEO) but reduced...Hace 12 horas
-
Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry - This drug stock has used recent declines as an opportunity to build a bullish base. Analysts see hearty price gains ahead.Hace 13 horas
-
Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry - This drug stock has used recent declines as an opportunity to build a bullish base. Analysts see hearty price gains ahead.Hace 13 horas
-
1 Stock Under $50 to Target This Week and 2 We Ignore - The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk t...Hace 14 horas
-
-
Fitch Ratings Upgrades Term Issuer Default Rating on British American Tobacco (BTI) - British American Tobacco p.l.c. (NYSE:BTI) is one of the Most Profitable Large Cap Stocks to Invest in Now. On March 13, Fitch Ratings upgraded its long-te...Hace 17 horas
-
NEW T. ROWE PRICE PODCAST EPISODE EXAMINES THE FUTURE OF AI AND HUMAN ADVANTAGE - T. Rowe Price, a global investment management firm and leader in retirement, announces a new episode of "The Angle from T. Rowe Price," its investment-them...Hace 17 horas
-
NEW T. ROWE PRICE PODCAST EPISODE EXAMINES THE FUTURE OF AI AND HUMAN ADVANTAGE - A conversation on AI, curiosity, and the skills that endure BALTIMORE, April 2, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and...Hace 17 horas
-
Zacks Industry Outlook Highlights Honeywell, 3M, ITT and Carlisle - Honeywell, 3M, ITT and Carlisle have been highlighted in this Industry Outlook article.Hace 22 horas
-
HSBC, NatWest, Nationwide and Halifax hike mortgage rates as Bank of England warns of Iran war impact - Find out the latest mortgage rates and deals from HSBC, NatWest, Santander, Barclays and more.Hace 23 horas
-
Do Options Traders Know Something About Skyworks Stock We Don't? - Investors need to pay close attention to SKWS stock based on the movements in the options market lately.Hace 1 día
-
AirJoule on Commercialization Path: Sales Will Start Soon - AirJoule is on track for commercialized operations and has a growing business pipeline to support a robust growth and profitability outlook.Hace 1 día
-
AirJoule on Commercialization Path: Sales Will Start Soon - AirJoule is on track for commercialized operations and has a growing business pipeline to support a robust growth and profitability outlook.Hace 1 día
-
Exdensur (depemokimab) approved in China for the treatment of severe asthma - Exdensur is the first and only ultra-long-acting biologic in China for the treatment of severe asthma with an eosinophilic phenotype.Hace 3 días
-
Randstad N.V. (AMS:RAND) Stock Goes Ex-Dividend In Just Three Days - Randstad N.V. ( AMS:RAND ) is about to trade ex-dividend in the next three days. Typically, the ex-dividend date is two...Hace 1 semana
-
How The Reckitt Benckiser (LSE:RKT) Story Is Shifting With Fresh Targets And Portfolio Moves - The latest analyst update on Reckitt Benckiser Group centers on a trimmed fair value estimate, moving from £67.29 to £65.63, alongside a raised price targe...Hace 1 semana
-
No hay comentarios:
Publicar un comentario